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The survey will use the
methods employed by Darwin
alongside modern botanical
survey techniques. Wildflower
and conservation enthusiasts will
be encouraged to help the
survey and their findings will be
collated and added to the
Natural History Museum’s
collections. They will be included
in the botany collection soon to
be housed in phase two of the
Darwin Centre. This phase will
provide new storage facilities to
safeguard millions of specimens
from the museum’s insect and
plant collections, preserving
them for generations to come. It
will also provide new state-of-
the-art laboratories for scientists
and give visitor access to these
important collections and the
research they support.
In addition to the survey a
programme of events and
activities, such as pond-dipping,
wildlife displays and guided
walks, will take place throughout
the summer to build an
understanding of the natural
world and Darwin’s work and to




landscape, owned by English
Heritage, are a proposed World
Heritage Site. Researchers and
enthusiasts are hoping the new
activities drawing together
history and science will help
bolster the bid for such status.
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Down and out: Darwin did much work




Norbert Perrimon is Professor of
Genetics at The Harvard Medical
School and an Investigator of the
Howard Hughes Medical Institute.
He grew up in Normandy and
obtained his graduate degree at
the University of Paris VI with
Mme. Madeleine Gans. He then
studied with Anthony Mahowald
at Case Western Reserve
University before taking a
position in 1986 at The Harvard
Medical School, where he has
been ever since. His main
contributions in science are
related to the development of
technologies for functional
genomics and dissection of
signal transduction pathways in
Drosophila.
How did you get into biology? I
grew up with a deep interest in
paleontology and evolution, which
led to an interest in
developmental biology. During my
undergraduate studies, I realized
that using genetics to study
Drosophila patterning could
answer many of the questions
that interested me. From then, I
was hooked. I love genetic tricks
and applying them to studying
biological processes, particularly
signal transduction pathways.
There is finality to the
development of a new
methodology that I like: it’s like
solving a math problem, except
that, in the end, there is a clear
application for the ‘solution’. This
is very rewarding.
Do you have a favourite paper?
Many, but the one that had the
most impact on my scientific
career was the first paper my
thesis advisor, Mme. Gans, gave
me to read: a clonal analysis of
the female germline by Eric
Wieschaus and Janos Szabad,
published in Developmental
Biology in 1979. It was in English,
which was not my strong point,
and contained a lot of genetic
jargon and methods. After I
mastered this paper, all others
were easy to read.
What is your favourite
conference? These days I prefer
small, workshop-like meetings
rather than large diffuse
conferences. To me a successful
meeting is when, on my return, I
have a clear overview of the
meeting topic and what the next
issues to be solved are.
Any strong views on the peer
review system? The peer review
system, even with all its flaws, is
the backbone of success in
research. It is what drives
excellence and ensures that the
money we are awarded to
conduct science is well spent.
How about the sharing of
reagents? I feel very strongly that
all published reagents must be
made freely available immediately
after publication. It guarantees
reproducibility in science and
stimulates further discoveries. I
make it a rule that all requests for
our published reagents be met
within one to two weeks. It can be
difficult for my graduate students
and postdocs to comply with this
rule, as in some cases it is clear
the reagents will directly benefit
our competitors, but the rule still
holds. As obtaining published
reagents is time consuming and
not always straightforward, in my
ideal world there would be a
centralized distribution repository
where all published reagents
would be sent at the time of
publication. This would also help
to ensure that, when a lab closes
down, the reagents remain
available to everyone.
Any advice for someone
wondering what area to study?
Follow your interests, not what is
trendy or what you think will lead
to a good job in a few years.
Identify an important biological
question, keeping in mind where
the question fits in the ‘big
picture’. Find the best system or
organism in which to address the
question, and apply to the lab
best fit to conduct the science.
There is a lot of emphasis these
days on ‘multidisciplinary
approaches’ in science. For
example, at the postdoctoral level,
some funding agencies emphasize
the importance of a shift in field or
organisms to increase the
applicant’s training potential.
Although I can understand this
trend, I’m not convinced that it’s
such an important issue. I have no
doubt that capable and innovative
students will always find the best
approach to solve whatever
problems they study. In the long
term, I believe it is more important
to work in a multidisciplinary
environment where a trainee will
be exposed to labs with diverse
approaches and backgrounds.
If you had to start all over
again, would you be a scientist
and if so in what field? I have no
doubt that I would be in science
as this has always been my center
of interest. But I’m not sure about
the precise area of study that I
would choose today. I believe that
when I was 24 years old I had
more readily available ‘facts’
about science in general,
including physics and math, than I
have now. I think it would be great
if I could step back and allow my
24 year old brain evaluate my
science today. My hope would be
that I would like what I saw.
Your ambitions? What I really
would like to understand is the
spatial and temporal organization
of a network of signaling
pathways, such as a receptor
tyrosine kinase pathway or the
Wnt pathway. There are so many
fundamental questions in signal
transduction that are far from
being solved. Where and when is
a ligand secreted, and how does it
interact with the extracellular
matrix? Is the transducing
receptor localized, and if it is,
what is the biological significance
of such compartmentalization?
How does the localization of
cytoplasmic proteins to a certain
region of a cell contribute to the
overall signaling characteristics of
the pathway? How are signaling
kinetics achieved in isolation or
within a network of
communicating pathways? I could
go on and on and on, but it’s time
for me to go and walk my dogs.
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Coral surprise
Recent reports indicate that
many shallow coral reefs in the
Caribbean, and other parts of
the world, are under threat
because of disease, pollution,
land run-off and possibly rising
seawater temperatures, that
have caused increased coral
mortality. But new studies on
deep-water coral reefs, feared
also to be under stress but little
studied because of their
inaccessibility, suggest the
contrary: they are in surprisingly
good shape.
Researchers from the Woods
Hole Oceanographic Institution
(WHOI) have been using a new
small craft to survey the deep
coral reefs surrounding the US
Virgin Islands and other
surrounding areas of the tropical
Atlantic. They have found that
these reefs may occupy a much
larger area and be in better
health than previously thought,
based on the evidence gathered
by the new autonomous vehicle.
Scientists and engineers
began using the underwater
vehicle to study deep-water
coral reefs and related
Deeper down: Strobe-illuminated pictures reveals coral life at new depths. (Photo:
WHOI and the University of Puerto Rico/Hanumant Singh and Roy Armstrong.)
